Search

AstraZeneca PLC

Closed

SectorHealthcare

162.21 -1.47

Overview

Share price change

24h

Current

Min

161.4

Max

162.74

Key metrics

By Trading Economics

Income

-1.4B

2.5B

Sales

96M

15B

P/E

Sector Avg

24.344

56.659

EPS

2.63

Dividend yield

1.99

Profit margin

16.095

Employees

96,100

EBITDA

-510M

5.2B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+34.9% upside

Dividends

By Acuity

Dividend yield

Sector Avg

1.99%

2.18%

Next Earnings

30 Oct 2026

Next Dividend date

8 Sept 2026

Market Stats

By TradingEconomics

Market Cap

-10B

251B

Previous open

163.68

Previous close

162.21

News Sentiment

By Acuity

35%

65%

100 / 339 Healthcare

AstraZeneca PLC Chart

Past performance is not a reliable indicator of future results.

Related News

4 Sept 2026, 23:40 UTC

News

DocuSign Inc. reported strong second-quarter results and raised guidance, yet shares are trading lower in after-market hours amid valuation concerns and economic context.

4 Sept 2026, 23:35 UTC

News

AAP shares lower in after-market hours on analyst rating updates.

4 Sept 2026, 23:27 UTC

News

Photronics Inc shares traded lower in after-market hours amid a securities class action lawsuit alleging fraud related to its product pipeline and demand stability.

4 Sept 2026, 23:20 UTC

News

Monster Beverage appoints Matthew S. Burroughs as Chief Accounting Officer and Deputy CFO, with shares rising in after-market trading.

4 Sept 2026, 23:10 UTC

News

Northrop Grumman was awarded a $508.49 million contract for flight test support by the U.S. Department of Defense, shares trading higher in after-market hours.

4 Sept 2026, 23:05 UTC

News

Pomerantz LLP filed a class action lawsuit against Replimune Group Inc for alleged securities fraud, contributing to a decline in shares during after-market hours.

4 Sept 2026, 23:02 UTC

News

Illumina Inc will join the S&P 500 index effective September 21, 2026, following an announcement by Dow Jones Indices. Shares are trading higher after the news.

4 Sept 2026, 23:02 UTC

Social Media
News

Star Bulk Carriers announced a parallel listing on Euronext Athens and an equity offering. Shares are lower in after-market hours following the news.

4 Sept 2026, 23:02 UTC

News

Ionis Pharmaceuticals shares declined in after-market trading following Novartis' announcement of the failed pelacarsen Phase 3 study to reduce cardiovascular events.

4 Sept 2026, 23:00 UTC

News

Bloom Energy shares are higher in after-market trading following its inclusion in the S&P 500, effective September 21, 2026.

4 Sept 2026, 23:00 UTC

News

FirstEnergy shares rise in after-market trading following Potomac Edison's $52.8 million rate adjustment proposal to enhance electric system reliability in Maryland.

4 Sept 2026, 23:00 UTC

News

Campbell's Co announced a restructuring plan, cutting 13% of salaried jobs and closing two plants. Shares are trading higher in after-market hours.

4 Sept 2026, 22:51 UTC

Correlated Moves
News

Shares rose in after-market trading amid strength in oil sector.

4 Sept 2026, 20:08 UTC

News

Planet Fitness Inc. is facing a securities class action lawsuit alleging misleading statements on customer growth, contributing to a decline in its stock during Friday's session.

4 Sept 2026, 20:08 UTC

News
Correlated Moves

Marten Transport Ltd shares are higher, supported by a broader transportation sector rally and an amended credit facility increasing the letters-of-credit sublimit to $50 million.

4 Sept 2026, 20:08 UTC

News

Jefferies Financial Group's shares are higher as it maintains "buy" ratings and raises price targets for several banks, including Barclays and Lloyds.

4 Sept 2026, 20:08 UTC

News

El Pollo Loco Holdings to participate in two investor conferences this month. Shares are trading higher, reflecting positive sentiment despite earlier session pullback.

4 Sept 2026, 20:08 UTC

News

Intuitive Surgical shares declined to $365.21, marking a four-week low. Ongoing market challenges contributed to the stock's downward movement during the session.

4 Sept 2026, 20:08 UTC

News
Social Media
Macro Event

McDonald's shares hit a 52-week low amid ongoing challenges, including high menu prices like $15 for an Egg McMuffin, reflecting a broader market decline.

4 Sept 2026, 20:08 UTC

News

OrthoPediatrics Corp shares are lower amid broader market declines and selling pressure following a strong jobs report. A major shareholder's recent sale adds to negative sentiment.

4 Sept 2026, 20:08 UTC

Social Media
Macro Event
News
Correlated Moves

Intel shares are higher as demand for CPUs surges, driven by AI workloads. Despite a price target cut to $92, investor sentiment remains positive.

4 Sept 2026, 20:08 UTC

News
Correlated Moves
Social Media

Advanced Micro Devices is rising as AI demand boosts projections for its EPYC CPUs, aided by partnerships like Microsoft’s Project Zenith.

4 Sept 2026, 20:08 UTC

News

Globus Medical Inc received CE mark approval for its Excelsius3D system, enabling sales in the EU and U.K. Shares are gaining during Friday's session.

4 Sept 2026, 20:08 UTC

News

PVH Corp reported a second-quarter loss of $102.9 million but shares are higher today, rebounding after an earlier dip during the session.

4 Sept 2026, 20:08 UTC

News
Correlated Moves

Douglas Dynamics declared a quarterly dividend of $0.295 per share, with shares rising today alongside Astec Industries' notable gain.

4 Sept 2026, 20:08 UTC

Macro Event
Social Media
News

Dell Technologies reported strong quarterly earnings, with revenue rising significantly. The stock reached a record high amid positive sentiment following the earnings beat.

4 Sept 2026, 20:08 UTC

News

Ollie's Bargain Outlet reported Q2 EPS of $1.42, surpassing estimates. Shares are higher amid positive sentiment following the earnings announcement.

4 Sept 2026, 20:08 UTC

News

Airbnb Inc. shares are declining as the EU proposes regulations on short-term rentals to address affordable housing shortages in tourist areas.

4 Sept 2026, 20:08 UTC

News

UnitedHealth Group will cut prior-authorization requirements across plans starting October 1. Shares are lower today, in line with broader market declines.

4 Sept 2026, 20:08 UTC

News

Teladoc Health Inc shares are lower today amid broader market declines following a strong jobs report raising concerns over tighter monetary policy.

Peer Comparison

Price change

AstraZeneca PLC Forecast

Price Target

By TipRanks

34.9% upside

12 Months Forecast

Average 219.474 USD  34.9%

High 273.043 USD

Low 155.446 USD

Based on 16 Wall Street analysts offering 12 month price targets forAstraZeneca PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

14

Buy

1

Hold

1

Sell

Sentiment

By Acuity

100 / 339 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
help-icon Live chat